Bristol-Myers Squibb Company

Organization

New York, NY, US

Ticker Symbols

NYSE:BMY

PHARMACEUTICAL PREPARATIONS
Business Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
Mailing Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
State Location
NY
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
- Patent number 12,365,667
- Issue date Jul 22, 2025
- Bristol-Myers Squibb Company
- Chunjian Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Supramolecular filamentous assemblies for protein purification
- Patent number 12,357,965
- Issue date Jul 15, 2025
- The Johns Hopkins University
- Honggang Cui
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Classifying documents using a domain-specific natural language proc...
- Patent number 12,353,479
- Issue date Jul 8, 2025
- Bristol-Myers Squibb Company
- Sameen Mayur Desai
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
System for verifying accuracy of serially-connected drug modules in...
- Patent number 12,343,498
- Issue date Jul 1, 2025
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted phenyl oxazolone compounds
- Patent number 12,331,045
- Issue date Jun 17, 2025
- Bristol-Myers Squibb Company
- Lan-Ying Qin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metabolic enzyme activity and disulfide bond reduction during prote...
- Patent number 12,325,875
- Issue date Jun 10, 2025
- Bristol-Myers Squibb Company
- Anthony Joseph Cura
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for regenerating chromatography resins
- Patent number 12,325,843
- Issue date Jun 10, 2025
- Bristol-Myers Squibb Company
- James Angelo
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information Patent Grant
Substituted amide compounds useful as farnesoid X receptor modulators
- Patent number 12,319,676
- Issue date Jun 3, 2025
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of AAV therapy
- Patent number 12,312,395
- Issue date May 27, 2025
- Bristol-Myers Squibb Company
- Uma Kavita
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies against TIM3 and uses thereof
- Patent number 12,312,403
- Issue date May 27, 2025
- Bristol-Myers Squibb Company
- Xiao Min Schebye
- G01 - MEASURING TESTING
Information Patent Grant
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inh...
- Patent number 12,304,916
- Issue date May 20, 2025
- Bristol-Myers Squibb Company
- Saleem Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4...
- Patent number 12,304,914
- Issue date May 20, 2025
- Bristol-Myers Squibb Company
- Hong Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody comprising a glutamine-containing light chain C-terminal e...
- Patent number 12,290,570
- Issue date May 6, 2025
- Bristol-Myers Squibb Company
- Pavel Strop
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Galectin-3 inhibitors
- Patent number 12,291,522
- Issue date May 6, 2025
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-...
- Patent number 12,291,517
- Issue date May 6, 2025
- Bristol-Myers Squibb Company
- Daniel Richard Roberts
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,286,424
- Issue date Apr 29, 2025
- Bristol-Myers Squibb Company
- Prasada Rao Jalagam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
- Patent number 12,286,428
- Issue date Apr 29, 2025
- Bristol-Myers Squibb Company
- Satheesh Kesavan Nair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use th...
- Patent number 12,281,085
- Issue date Apr 22, 2025
- Immunome, Inc.
- Matti Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolidinone derivatives as formyl peptide 2 receptor agonists
- Patent number 12,281,108
- Issue date Apr 22, 2025
- Bristol-Myers Squibb Company
- Nicholas R. Wurtz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indicating differences in and reconciling data stored in disparate...
- Patent number 12,282,492
- Issue date Apr 22, 2025
- Bristol-Myers Squibb Company
- Sahith Doppalapudi
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,275,719
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,275,720
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Prasada Rao Jalagam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indazole carboxamides as kinase inhibitors
- Patent number 12,275,721
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Jie Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of galectin-3
- Patent number 12,275,718
- Issue date Apr 15, 2025
- Bristol-Myers Squibb Company
- Jacob Swidorski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Small molecule inhibitors of Galectin-3
- Patent number 12,269,819
- Issue date Apr 8, 2025
- Bristol-Myers Squibb Company
- Chunjian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of a cyclic dinucleotide
- Patent number 12,269,840
- Issue date Apr 8, 2025
- Bristol-Myers Squibb Company
- Michael Anthony Schmidt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding modified FGF-21 polypeptides, vectors and ce...
- Patent number 12,247,058
- Issue date Mar 11, 2025
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 12,241,065
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Amide-substituted heterocyclic compounds for the treatment of condi...
- Patent number 12,240,840
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Steven H. Spergel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of controlling the pink color generated during antibody manu...
- Patent number 12,241,107
- Issue date Mar 4, 2025
- Bristol-Myers Squibb Company
- Cheng Du
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
- Publication number 20250236650
- Publication date Jul 24, 2025
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
- Publication number 20250230144
- Publication date Jul 17, 2025
- Bristol-Myers Squibb Company
- James A. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS
- Publication number 20250230251
- Publication date Jul 17, 2025
- Bristol-Myers Squibb Company
- Lin Hui SU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL CONTAINING COMPOUNDS USEFUL AS...
- Publication number 20250230153
- Publication date Jul 17, 2025
- Bristol-Myers Squibb Company
- Timothy P. Connolly
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RXFP1 AGONISTS
- Publication number 20250221966
- Publication date Jul 10, 2025
- Bristol-Myers Squibb Company
- Shun Su
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA
- Publication number 20250215076
- Publication date Jul 3, 2025
- Bristol-Myers Squibb Company
- Rebecca Anne MOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS FOR IMPROVING ORAL BIOAVAILABILITY
- Publication number 20250213548
- Publication date Jul 3, 2025
- Bristol-Myers Squibb Company
- Bo LANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT
- Publication number 20250215087
- Publication date Jul 3, 2025
- Bristol-Myers Squibb Company
- David Julian Harry DOWNWARD
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF ISOLATING POLYPEPTIDES
- Publication number 20250206775
- Publication date Jun 26, 2025
- Bristol-Myers Squibb Company
- Elizabeth BIGELOW
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Binding to Vista at Acidic pH
- Publication number 20250206822
- Publication date Jun 26, 2025
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Compositions and Methods of Use Thereof
- Publication number 20250205334
- Publication date Jun 26, 2025
- Bristol-Myers Squibb Company
- Masano HUANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Leveraging Large Language Models for Automating Lines of Therapy Ad...
- Publication number 20250201375
- Publication date Jun 19, 2025
- Bristol-Myers Squibb Company
- Shamsulhaq Basir
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
WEE1 DEGRADING COMPOUNDS AND USES THEREOF
- Publication number 20250197374
- Publication date Jun 19, 2025
- Bristol-Myers Squibb Company
- Jesus MORENO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR THE PREPARATION OF A CYCLIC DINUCLEOTIDE
- Publication number 20250197440
- Publication date Jun 19, 2025
- Bristol-Myers Squibb Company
- Michael Anthony Schmidt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3
- Publication number 20250197494
- Publication date Jun 19, 2025
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES
- Publication number 20250197495
- Publication date Jun 19, 2025
- Bristol-Myers Squibb Company
- Andres A. GUTIERREZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF
- Publication number 20250188463
- Publication date Jun 12, 2025
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRANSIENT EXPRESSION OF THERAPEUTIC PROTEINS
- Publication number 20250188152
- Publication date Jun 12, 2025
- Bristol-Myers Squibb Company
- Kitty AGARWAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY FOR COLORECTAL CARCINOMA
- Publication number 20250179174
- Publication date Jun 5, 2025
- Bristol-Myers Squibb Company
- Rebecca Anne MOSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED IMIDAZOPYRIDINYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9
- Publication number 20250177363
- Publication date Jun 5, 2025
- Bristol-Myers Squibb Company
- David S. Yoon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...
- Publication number 20250179140
- Publication date Jun 5, 2025
- Bristol-Myers Squibb Company
- Mary STRUTHERS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS
- Publication number 20250171538
- Publication date May 29, 2025
- Bristol-Myers Squibb Company
- Anke KLIPPEL
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF PRODUCING RECOMBINANT PROTEINS
- Publication number 20250171732
- Publication date May 29, 2025
- Bristol-Myers Squibb Company
- Jianlin XU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Machine-Learning Models for Prognosing Outcomes For Hypertrophic Ca...
- Publication number 20250174357
- Publication date May 29, 2025
- Bristol-Myers Squibb Company
- Arnaud Bastien
Information Patent Application
SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9
- Publication number 20250163054
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- David S. Yoon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TR...
- Publication number 20250163155
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20250163004
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Steven H. Spergel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC IMMUNOMODULATORS
- Publication number 20250163104
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Jennifer X. QIAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS INHIBITORS
- Publication number 20250163046
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Brian Edward FINK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Their Use for Treatment of Hemoglobinopathies
- Publication number 20250163025
- Publication date May 22, 2025
- Bristol-Myers Squibb Company
- Thomas J. Cummins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
99262248 - QBEYOND
- Serial number 99262248
- Filing date Jul 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99262241 - OPDUALAG QBEYOND
- Serial number 99262241
- Filing date Jul 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256180 - ADBRESQA
- Serial number 99256180
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256124 - ZYWISPO
- Serial number 99256124
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256146 - SYWISPO
- Serial number 99256146
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256158 - FLOWISPO
- Serial number 99256158
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256163 - AMWISPO
- Serial number 99256163
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256130 - ZELWISPO
- Serial number 99256130
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256160 - ANWISPI
- Serial number 99256160
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256152 - HYWISPO
- Serial number 99256152
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256179 - ADHAYLU
- Serial number 99256179
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256143 - WELWISPO
- Serial number 99256143
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256134 - LYFAVYZE
- Serial number 99256134
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256173 - AHWISPO
- Serial number 99256173
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256139 - WINDUVEO
- Serial number 99256139
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256149 - LIFAVYZE
- Serial number 99256149
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256176 - ADMUVEO
- Serial number 99256176
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99256171 - AIRDELPA
- Serial number 99256171
- Filing date Jun 27, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99169291 - OPDUALAG QSONI
- Serial number 99169291
- Filing date May 5, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165552 - QSISTEN
- Serial number 99165552
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165553 - QSONI
- Serial number 99165553
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165556 - OPDUALAG QSIST
- Serial number 99165556
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165576 - OPDUALAG QSOVE
- Serial number 99165576
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165581 - OPDUALAG QUFECTO
- Serial number 99165581
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165591 - OPDUALAG QFECTO
- Serial number 99165591
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165548 - QBYON
- Serial number 99165548
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165550 - OPDUALAG QSISTEN
- Serial number 99165550
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165602 - OPDUALAG QLESK
- Serial number 99165602
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165606 - OPDUALAG QBERI
- Serial number 99165606
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99165539 - OPDUALAG QBYON
- Serial number 99165539
- Filing date May 1, 2025
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations

Bristol-Myers Squibb Company

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

Supramolecular filamentous assemblies for protein purification

Classifying documents using a domain-specific natural language proc...

System for verifying accuracy of serially-connected drug modules in...

Substituted phenyl oxazolone compounds

Metabolic enzyme activity and disulfide bond reduction during prote...

Methods for regenerating chromatography resins

Substituted amide compounds useful as farnesoid X receptor modulators

Methods of AAV therapy

Antibodies against TIM3 and uses thereof

Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inh...

Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4...

Antibody comprising a glutamine-containing light chain C-terminal e...

Galectin-3 inhibitors

Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-...

Small molecule inhibitors of galectin-3

Tricyclic heteroaryl compounds useful as IRAK4 inhibitors

Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use th...

Pyrrolidinone derivatives as formyl peptide 2 receptor agonists

Indicating differences in and reconciling data stored in disparate...

Small molecule inhibitors of galectin-3

Small molecule inhibitors of galectin-3

Indazole carboxamides as kinase inhibitors

Small molecule inhibitors of galectin-3

Small molecule inhibitors of Galectin-3

Process for the preparation of a cyclic dinucleotide

Nucleic acids encoding modified FGF-21 polypeptides, vectors and ce...

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Amide-substituted heterocyclic compounds for the treatment of condi...

Method of controlling the pink color generated during antibody manu...

Patents Applicationslast 30 patents

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS

2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL CONTAINING COMPOUNDS USEFUL AS...

RXFP1 AGONISTS

COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA

PHARMACEUTICAL COMPOSITIONS FOR IMPROVING ORAL BIOAVAILABILITY

COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT

METHODS OF ISOLATING POLYPEPTIDES

Antibodies Binding to Vista at Acidic pH

Antibody Compositions and Methods of Use Thereof

Leveraging Large Language Models for Automating Lines of Therapy Ad...

WEE1 DEGRADING COMPOUNDS AND USES THEREOF

PROCESS FOR THE PREPARATION OF A CYCLIC DINUCLEOTIDE

METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3

ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

TRANSIENT EXPRESSION OF THERAPEUTIC PROTEINS

COMBINATION THERAPY FOR COLORECTAL CARCINOMA

SUBSTITUTED IMIDAZOPYRIDINYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9

INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METH...

TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS

METHODS OF PRODUCING RECOMBINANT PROTEINS

Machine-Learning Models for Prognosing Outcomes For Hypertrophic Ca...

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9

COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TR...

SUBSTITUTED HETEROCYCLIC COMPOUNDS

MACROCYCLIC IMMUNOMODULATORS

KRAS INHIBITORS

Compounds and Their Use for Treatment of Hemoglobinopathies

Trademarklast 30 trademarks

99262248 - QBEYOND

99262241 - OPDUALAG QBEYOND

99256180 - ADBRESQA

99256124 - ZYWISPO

99256146 - SYWISPO

99256158 - FLOWISPO

99256163 - AMWISPO

99256130 - ZELWISPO

99256160 - ANWISPI

99256152 - HYWISPO